← Browse by Condition
Medical Condition

crohn disease

Total Trials
28
Recruiting Now
28
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for crohn disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — crohn disease Clinical Trials

How many clinical trials are currently recruiting for crohn disease?
ClinicalMetric currently tracks 28 actively recruiting clinical trials for crohn disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 28. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for crohn disease?
crohn disease research spans Phase 1 (2 trials), Phase 2 (4 trials), Phase 3 (1 trial), Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a crohn disease clinical trial?
Eligibility criteria for crohn disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
4
Phase 3
1
Phase 4
3
Top Sponsors
University of California, San Diego 2 trials
Seoul National University Bundang Hospital 1 trial
Aaron Etra 1 trial
University Hospital, Clermont-Ferrand 1 trial
Children's Hospital Medical Center, Cincinnati 1 trial

Recruiting Clinical Trials

NCT05653011
Recruiting
Predictors of Prognosis in IBD Patients
Enrollment
100 pts
Location
South Korea
Sponsor
Seoul National University Bund...
View Trial →
NCT03219359 Phase 2
Recruiting
Autologous Stem Cell Transplant for Crohn's Disease
Enrollment
50 pts
Location
United States
Sponsor
Aaron Etra
View Trial →
NCT04973423
Recruiting
STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
Enrollment
180 pts
Location
France
Sponsor
University Hospital, Clermont-...
View Trial →
NCT03847467 Phase 1, Phase 2
Recruiting
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
Enrollment
116 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
View Trial →
NCT03571373
Recruiting
PIBD-SETQuality: the Inception Cohort and Safety Registry
Enrollment
1,500 pts
Location
Netherlands, United ...
Sponsor
PIBD-Net
View Trial →
NCT04372108
Recruiting
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Enrollment
1,056 pts
Location
United States
Sponsor
Janssen Scientific Affairs, LL...
View Trial →
NCT05040464 Phase 3
Recruiting
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
Enrollment
166 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT06042387
Recruiting
Genome Analysis Across Populations in Inflammatory Bowel Disease
Enrollment
150 pts
Location
Canada
Sponsor
Mount Sinai Hospital, Canada
View Trial →
NCT04946448
Recruiting
COmbinAtion Therapy of dieT With biologicalS for Crohn's Disease: the OATS Study
Enrollment
144 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
View Trial →
NCT06252493
Recruiting
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Enrollment
25 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT04751396
Recruiting
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Enrollment
125 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT04263831 Phase 1, Phase 2
Recruiting
Low Dose IL-2 for the Treatment of Crohn's Disease
Enrollment
30 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT03917303 Phase 4
Recruiting
Control Crohn Safe Trial
Enrollment
158 pts
Location
Netherlands
Sponsor
Maastricht University Medical ...
View Trial →
NCT06197334
Recruiting
Gastro-intestinal Biopotential Recorder by Means of Surface ELEctrodes
Enrollment
60 pts
Location
France
Sponsor
Central Hospital, Nancy, Franc...
View Trial →
NCT06890650
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease
Enrollment
168 pts
Location
India
Sponsor
All India Institute of Medical...
View Trial →
NCT06257706 Phase 4
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Enrollment
304 pts
Location
United States, Austr...
Sponsor
Alimentiv Inc.
View Trial →
NCT06520397 Phase 4
Recruiting
Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
Enrollment
214 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
View Trial →
NCT06089590
Recruiting
Ibd CAncer and seRious Infections in France (I-CARE 2)
Enrollment
6,000 pts
Location
France
Sponsor
Groupe d'Etude Therapeutique d...
View Trial →
NCT07456566
Recruiting
Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
Enrollment
40 pts
Location
United States
Sponsor
University of Michigan
View Trial →
NCT07541261
Recruiting
A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
Enrollment
100 pts
Location
Saudi Arabia
Sponsor
Janssen Research & Development...
View Trial →
NCT07141238
Recruiting
Microplastic Analysis in Pediatric Inflammatory Bowel Disease
Enrollment
40 pts
Location
Poland
Sponsor
Medical University of Gdansk
View Trial →
NCT06555042
Recruiting
Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
Enrollment
20 pts
Location
Finland
Sponsor
Turku University Hospital
View Trial →
NCT06631586 Phase 2
Recruiting
Standardized Microbiota Transplant Therapy in Crohn's Disease
Enrollment
120 pts
Location
United States
Sponsor
University of Minnesota
View Trial →
NCT07198113
Recruiting
COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
Enrollment
1,100 pts
Location
United States
Sponsor
University of North Carolina, ...
View Trial →
NCT04192825
Recruiting
Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease
Enrollment
440 pts
Location
France
Sponsor
Rennes University Hospital
View Trial →
NCT06995170
Recruiting
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
Enrollment
146 pts
Location
China
Sponsor
Xijing Hospital
View Trial →
NCT05230173
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Enrollment
250 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT02103361
Recruiting
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Enrollment
200 pts
Location
United States
Sponsor
University of California, San ...
View Trial →

Related Conditions

inflammatory bowel diseases (10) ulcerative colitis (8) colitis ulcerative (2) healthy (2) psoriasis (2) psoriatic arthritis (2) calprotectin (1) mri (1) azathioprine (1) methotrexate (1) diet healthy (1) ankylosing spondylitis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology